RxDoctor Payments Data

William Oliva, MD

Child & Adolescent Psychiatry · Spencer, OKNPI 1356781199

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,583in general payments, 2019–2025

Across 152 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$413
  • AbbVie$329
  • Corium, LLC$278
  • Teva Pharmaceuticals USA, Inc.$249
  • Supernus Pharmaceuticals, Inc.$223
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$179
  • plus $912 from 13 others

What the payments were for

  • Food & beverage$2,583100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,583 in reported general payments places this provider in the 90th percentile of 34 child & adolescent psychiatry providers in Oklahoma.

See all child & adolescent psychiatry providers in Oklahoma

Medicare billing

Part B allowed, 2024
$12,325
Medicare patients
46
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine28$1,634
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine48$1,448
Lurasidone Hcl19$1,412
Methylphenidate Hcl31$753
Bupropion XlBupropion Hcl51$635
Sertraline Hcl28$263
Buprenorphine Hcl12$236
Quetiapine Fumarate20$230
Paroxetine Hcl18$202
Mirtazapine18$97
Olanzapine13$73
Escitalopram Oxalate12$68

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Spencer

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →